 Wei Perng
Concepts (374)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adiposity | 29 | 2023 | 457 | 7.470 |
Why?
| | Prenatal Exposure Delayed Effects | 18 | 2023 | 452 | 5.430 |
Why?
| | Body Mass Index | 46 | 2024 | 1958 | 4.310 |
Why?
| | Pediatric Obesity | 13 | 2023 | 489 | 3.380 |
Why?
| | Diabetes, Gestational | 9 | 2023 | 281 | 3.220 |
Why?
| | Environmental Pollutants | 7 | 2022 | 110 | 2.960 |
Why?
| | Pregnancy | 57 | 2024 | 5524 | 2.750 |
Why?
| | Birth Weight | 16 | 2023 | 440 | 2.690 |
Why?
| | Non-alcoholic Fatty Liver Disease | 8 | 2023 | 245 | 2.640 |
Why?
| | Biomarkers | 25 | 2023 | 3414 | 2.570 |
Why?
| | Weight Gain | 11 | 2023 | 451 | 2.540 |
Why?
| | Diet | 17 | 2023 | 1080 | 2.520 |
Why?
| | Cardiovascular Diseases | 10 | 2023 | 1727 | 2.240 |
Why?
| | Obesity | 24 | 2024 | 2513 | 2.230 |
Why?
| | Metabolomics | 12 | 2024 | 527 | 2.210 |
Why?
| | Body Composition | 15 | 2023 | 592 | 2.070 |
Why?
| | Leptin | 9 | 2023 | 211 | 2.020 |
Why?
| | Endocrine Disruptors | 3 | 2021 | 34 | 1.970 |
Why?
| | Child | 70 | 2024 | 18348 | 1.930 |
Why?
| | Mothers | 9 | 2024 | 651 | 1.930 |
Why?
| | Epigenesis, Genetic | 8 | 2023 | 521 | 1.900 |
Why?
| | DNA Methylation | 9 | 2023 | 496 | 1.870 |
Why?
| | Metabolic Syndrome | 5 | 2021 | 323 | 1.750 |
Why?
| | Insulin | 8 | 2023 | 2079 | 1.720 |
Why?
| | Environmental Exposure | 6 | 2022 | 374 | 1.720 |
Why?
| | Female | 100 | 2024 | 59483 | 1.660 |
Why?
| | Overweight | 8 | 2024 | 471 | 1.570 |
Why?
| | Overnutrition | 3 | 2021 | 30 | 1.560 |
Why?
| | Infant, Newborn | 30 | 2023 | 5034 | 1.510 |
Why?
| | Body Weight | 7 | 2022 | 869 | 1.500 |
Why?
| | Child Health | 3 | 2023 | 126 | 1.470 |
Why?
| | Stress, Psychological | 3 | 2023 | 944 | 1.460 |
Why?
| | Prospective Studies | 29 | 2023 | 6215 | 1.450 |
Why?
| | Premature Birth | 6 | 2022 | 276 | 1.440 |
Why?
| | Humans | 121 | 2024 | 114709 | 1.380 |
Why?
| | Hypertension, Pregnancy-Induced | 5 | 2022 | 45 | 1.360 |
Why?
| | Adolescent | 42 | 2023 | 17806 | 1.360 |
Why?
| | Body Height | 5 | 2018 | 180 | 1.310 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2023 | 2096 | 1.290 |
Why?
| | Long Interspersed Nucleotide Elements | 3 | 2013 | 25 | 1.280 |
Why?
| | Metabolome | 4 | 2020 | 283 | 1.250 |
Why?
| | Pregnancy Outcome | 5 | 2022 | 337 | 1.250 |
Why?
| | Waist Circumference | 9 | 2022 | 122 | 1.160 |
Why?
| | Child, Preschool | 36 | 2024 | 9077 | 1.150 |
Why?
| | Health Status | 2 | 2023 | 723 | 1.120 |
Why?
| | Metabolic Diseases | 4 | 2021 | 99 | 1.060 |
Why?
| | Risk Factors | 23 | 2023 | 8625 | 1.060 |
Why?
| | Nutritional Status | 4 | 2020 | 286 | 1.040 |
Why?
| | Mexico | 11 | 2023 | 162 | 1.020 |
Why?
| | Puberty | 4 | 2022 | 135 | 1.020 |
Why?
| | Amino Acids, Branched-Chain | 4 | 2022 | 31 | 1.020 |
Why?
| | Cohort Studies | 20 | 2023 | 4899 | 1.010 |
Why?
| | Male | 60 | 2023 | 55554 | 1.010 |
Why?
| | Blood Glucose | 9 | 2023 | 1821 | 0.980 |
Why?
| | Fluorocarbons | 2 | 2022 | 94 | 0.930 |
Why?
| | Child Development | 6 | 2023 | 387 | 0.920 |
Why?
| | Maternal Nutritional Physiological Phenomena | 4 | 2023 | 141 | 0.920 |
Why?
| | Skinfold Thickness | 4 | 2018 | 49 | 0.910 |
Why?
| | C-Reactive Protein | 7 | 2017 | 362 | 0.910 |
Why?
| | Insulin Resistance | 8 | 2021 | 1072 | 0.890 |
Why?
| | Psychological Tests | 1 | 2023 | 120 | 0.840 |
Why?
| | Lead | 2 | 2021 | 43 | 0.840 |
Why?
| | Fetal Blood | 3 | 2022 | 270 | 0.840 |
Why?
| | Self Report | 4 | 2023 | 695 | 0.830 |
Why?
| | Anti-Mullerian Hormone | 1 | 2023 | 50 | 0.830 |
Why?
| | Blood Pressure | 7 | 2022 | 1530 | 0.820 |
Why?
| | Sexual Maturation | 2 | 2019 | 47 | 0.800 |
Why?
| | Pregnancy Proteins | 1 | 2022 | 36 | 0.790 |
Why?
| | Azocines | 1 | 2021 | 4 | 0.790 |
Why?
| | Insulins | 1 | 2022 | 32 | 0.780 |
Why?
| | Adiponectin | 4 | 2023 | 213 | 0.770 |
Why?
| | Ecology | 1 | 2022 | 97 | 0.770 |
Why?
| | Hyaenidae | 1 | 2021 | 3 | 0.770 |
Why?
| | Cardiovascular System | 1 | 2023 | 125 | 0.760 |
Why?
| | Phthalic Acids | 2 | 2022 | 28 | 0.750 |
Why?
| | Adult | 31 | 2023 | 30542 | 0.750 |
Why?
| | Biological Evolution | 2 | 2022 | 416 | 0.740 |
Why?
| | Maternal Behavior | 1 | 2021 | 70 | 0.740 |
Why?
| | Triglycerides | 7 | 2023 | 470 | 0.720 |
Why?
| | Hyperinsulinism | 1 | 2021 | 103 | 0.710 |
Why?
| | Infant | 23 | 2024 | 7932 | 0.710 |
Why?
| | Racism | 1 | 2022 | 102 | 0.700 |
Why?
| | Prediabetic State | 1 | 2023 | 220 | 0.690 |
Why?
| | Placenta | 3 | 2023 | 626 | 0.690 |
Why?
| | Young Adult | 20 | 2023 | 10461 | 0.690 |
Why?
| | Lipids | 3 | 2020 | 582 | 0.680 |
Why?
| | Social Environment | 1 | 2021 | 283 | 0.670 |
Why?
| | Islets of Langerhans | 2 | 2023 | 728 | 0.650 |
Why?
| | Epidemiology | 1 | 2018 | 14 | 0.640 |
Why?
| | Longitudinal Studies | 12 | 2023 | 2381 | 0.620 |
Why?
| | Adipose Tissue | 5 | 2020 | 539 | 0.620 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 2018 | 67 | 0.610 |
Why?
| | Cholesterol | 4 | 2023 | 368 | 0.600 |
Why?
| | Linear Models | 8 | 2024 | 770 | 0.600 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2018 | 10 | 0.600 |
Why?
| | Sex Characteristics | 2 | 2020 | 635 | 0.600 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2018 | 45 | 0.600 |
Why?
| | Homeostasis | 2 | 2021 | 575 | 0.590 |
Why?
| | Body Fluid Compartments | 1 | 2017 | 5 | 0.580 |
Why?
| | Insulin-Like Growth Factor II | 1 | 2017 | 23 | 0.580 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2017 | 38 | 0.580 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2018 | 122 | 0.560 |
Why?
| | Bone and Bones | 1 | 2019 | 278 | 0.550 |
Why?
| | Maternal Exposure | 2 | 2020 | 138 | 0.540 |
Why?
| | MicroRNAs | 1 | 2022 | 601 | 0.540 |
Why?
| | Androgens | 1 | 2018 | 167 | 0.540 |
Why?
| | Feeding Behavior | 3 | 2023 | 574 | 0.540 |
Why?
| | Breast Feeding | 4 | 2024 | 370 | 0.530 |
Why?
| | Anthropometry | 6 | 2022 | 183 | 0.520 |
Why?
| | Fetal Development | 1 | 2018 | 246 | 0.520 |
Why?
| | Diabetes Mellitus | 2 | 2023 | 904 | 0.510 |
Why?
| | Micronutrients | 2 | 2013 | 78 | 0.500 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 286 | 0.490 |
Why?
| | Maternal Welfare | 1 | 2014 | 14 | 0.480 |
Why?
| | alpha-Linolenic Acid | 1 | 2014 | 7 | 0.480 |
Why?
| | Inflammation | 4 | 2022 | 2481 | 0.480 |
Why?
| | Colombia | 6 | 2018 | 34 | 0.480 |
Why?
| | Hyperhomocysteinemia | 1 | 2013 | 24 | 0.450 |
Why?
| | Alu Elements | 1 | 2013 | 26 | 0.450 |
Why?
| | Abdominal Fat | 3 | 2023 | 39 | 0.440 |
Why?
| | Homocysteine | 1 | 2013 | 136 | 0.430 |
Why?
| | Iron, Dietary | 1 | 2013 | 19 | 0.430 |
Why?
| | Intra-Abdominal Fat | 3 | 2023 | 77 | 0.420 |
Why?
| | Fatty Acids | 2 | 2020 | 382 | 0.420 |
Why?
| | Follow-Up Studies | 8 | 2022 | 4420 | 0.420 |
Why?
| | Growth Disorders | 1 | 2013 | 77 | 0.410 |
Why?
| | Poliomyelitis | 1 | 2012 | 27 | 0.400 |
Why?
| | Endotoxins | 2 | 2023 | 204 | 0.400 |
Why?
| | Sex Factors | 4 | 2019 | 1717 | 0.390 |
Why?
| | Infertility | 2 | 2022 | 45 | 0.390 |
Why?
| | Postpartum Period | 3 | 2020 | 281 | 0.390 |
Why?
| | Socioeconomic Factors | 6 | 2016 | 1078 | 0.390 |
Why?
| | Diseases in Twins | 1 | 2012 | 174 | 0.370 |
Why?
| | Hypertension | 2 | 2015 | 1059 | 0.360 |
Why?
| | Twins | 1 | 2012 | 240 | 0.360 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2023 | 3248 | 0.350 |
Why?
| | Atherosclerosis | 1 | 2013 | 342 | 0.350 |
Why?
| | Causality | 2 | 2021 | 104 | 0.350 |
Why?
| | Age of Onset | 2 | 2022 | 447 | 0.340 |
Why?
| | C-Peptide | 2 | 2021 | 138 | 0.330 |
Why?
| | Gestational Age | 3 | 2023 | 759 | 0.310 |
Why?
| | Fatty Liver | 2 | 2021 | 213 | 0.310 |
Why?
| | Principal Component Analysis | 3 | 2019 | 176 | 0.300 |
Why?
| | Logistic Models | 3 | 2023 | 1843 | 0.300 |
Why?
| | Boston | 3 | 2018 | 75 | 0.300 |
Why?
| | Massachusetts | 2 | 2019 | 134 | 0.290 |
Why?
| | Cross-Sectional Studies | 6 | 2021 | 4406 | 0.280 |
Why?
| | Interleukin-6 | 3 | 2014 | 675 | 0.270 |
Why?
| | Liver | 3 | 2023 | 1631 | 0.270 |
Why?
| | Air Pollution | 2 | 2020 | 169 | 0.260 |
Why?
| | Multivariate Analysis | 5 | 2016 | 1435 | 0.260 |
Why?
| | Regression Analysis | 3 | 2018 | 946 | 0.260 |
Why?
| | Incidence | 3 | 2023 | 2312 | 0.260 |
Why?
| | Genome-Wide Association Study | 2 | 2023 | 1197 | 0.250 |
Why?
| | Odds Ratio | 3 | 2023 | 954 | 0.250 |
Why?
| | Hyperglycemia | 2 | 2018 | 292 | 0.250 |
Why?
| | Air Pollutants | 2 | 2020 | 244 | 0.250 |
Why?
| | Pregnancy Complications | 3 | 2020 | 429 | 0.240 |
Why?
| | Health Behavior | 3 | 2021 | 704 | 0.240 |
Why?
| | Genetic Association Studies | 2 | 2019 | 344 | 0.240 |
Why?
| | Colorado | 4 | 2023 | 4085 | 0.230 |
Why?
| | Asthma | 4 | 2023 | 2032 | 0.230 |
Why?
| | Birth Order | 1 | 2023 | 12 | 0.220 |
Why?
| | Phenotype | 2 | 2022 | 2811 | 0.220 |
Why?
| | Age Factors | 3 | 2019 | 2889 | 0.210 |
Why?
| | Parturition | 2 | 2022 | 54 | 0.210 |
Why?
| | Menopause | 2 | 2022 | 271 | 0.210 |
Why?
| | Vegetables | 2 | 2020 | 133 | 0.200 |
Why?
| | Insulin, Regular, Human | 1 | 2022 | 33 | 0.200 |
Why?
| | Alkanesulfonic Acids | 1 | 2022 | 28 | 0.200 |
Why?
| | Michigan | 2 | 2020 | 96 | 0.200 |
Why?
| | Lysine | 1 | 2024 | 242 | 0.200 |
Why?
| | Pregnant Women | 1 | 2023 | 131 | 0.200 |
Why?
| | Cholesterol, LDL | 2 | 2022 | 307 | 0.200 |
Why?
| | Hand Strength | 1 | 2022 | 95 | 0.190 |
Why?
| | Educational Status | 1 | 2023 | 410 | 0.190 |
Why?
| | Carbohydrates | 1 | 2021 | 55 | 0.190 |
Why?
| | Toxoplasmosis, Animal | 1 | 2021 | 5 | 0.190 |
Why?
| | American Heart Association | 1 | 2023 | 264 | 0.190 |
Why?
| | Plethysmography | 2 | 2022 | 104 | 0.190 |
Why?
| | Antibodies, Protozoan | 1 | 2021 | 29 | 0.190 |
Why?
| | Toxoplasma | 1 | 2021 | 30 | 0.190 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2023 | 482 | 0.190 |
Why?
| | Latin America | 1 | 2021 | 69 | 0.190 |
Why?
| | Sarcopenia | 1 | 2022 | 63 | 0.190 |
Why?
| | Cats | 1 | 2021 | 193 | 0.180 |
Why?
| | Protective Factors | 1 | 2021 | 87 | 0.180 |
Why?
| | Middle Aged | 9 | 2023 | 26747 | 0.180 |
Why?
| | Selection, Genetic | 1 | 2022 | 243 | 0.180 |
Why?
| | Pre-Eclampsia | 1 | 2022 | 165 | 0.170 |
Why?
| | Precision Medicine | 1 | 2023 | 338 | 0.170 |
Why?
| | Scotland | 1 | 2019 | 12 | 0.170 |
Why?
| | Problem Behavior | 1 | 2021 | 86 | 0.170 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2022 | 359 | 0.160 |
Why?
| | Pilot Projects | 1 | 2023 | 1370 | 0.160 |
Why?
| | Health Surveys | 1 | 2021 | 443 | 0.160 |
Why?
| | Fasting | 1 | 2020 | 242 | 0.160 |
Why?
| | Data Interpretation, Statistical | 1 | 2021 | 322 | 0.160 |
Why?
| | Feces | 1 | 2021 | 374 | 0.160 |
Why?
| | Acetylcarnitine | 1 | 2018 | 4 | 0.160 |
Why?
| | Lipopolysaccharides | 1 | 2022 | 812 | 0.160 |
Why?
| | Aminoisobutyric Acids | 1 | 2018 | 7 | 0.160 |
Why?
| | Hydroxyproline | 1 | 2018 | 22 | 0.160 |
Why?
| | Ornithine | 1 | 2018 | 18 | 0.160 |
Why?
| | Asparagine | 1 | 2018 | 29 | 0.160 |
Why?
| | Milk, Human | 1 | 2020 | 128 | 0.160 |
Why?
| | Models, Theoretical | 1 | 2022 | 516 | 0.160 |
Why?
| | Carnitine | 1 | 2018 | 62 | 0.150 |
Why?
| | Comorbidity | 1 | 2023 | 1449 | 0.150 |
Why?
| | Food Hypersensitivity | 1 | 2022 | 253 | 0.150 |
Why?
| | Immunoglobulin G | 1 | 2022 | 774 | 0.150 |
Why?
| | Phospholipids | 1 | 2019 | 197 | 0.150 |
Why?
| | Tobacco Smoke Pollution | 1 | 2021 | 217 | 0.150 |
Why?
| | Energy Metabolism | 2 | 2021 | 729 | 0.150 |
Why?
| | History, 21st Century | 1 | 2018 | 160 | 0.150 |
Why?
| | Infant, Small for Gestational Age | 1 | 2018 | 76 | 0.150 |
Why?
| | Economic Development | 1 | 2017 | 3 | 0.150 |
Why?
| | Mass Spectrometry | 2 | 2018 | 633 | 0.150 |
Why?
| | Health Promotion | 1 | 2023 | 686 | 0.140 |
Why?
| | Glucocorticoids | 1 | 2021 | 532 | 0.140 |
Why?
| | Snacks | 2 | 2015 | 17 | 0.140 |
Why?
| | Dietary Fats | 2 | 2018 | 287 | 0.140 |
Why?
| | Mexican Americans | 1 | 2017 | 102 | 0.130 |
Why?
| | Cognition | 1 | 2023 | 983 | 0.130 |
Why?
| | Anxiety | 1 | 2022 | 840 | 0.130 |
Why?
| | Glucose Tolerance Test | 1 | 2017 | 343 | 0.130 |
Why?
| | Glucose | 1 | 2021 | 897 | 0.130 |
Why?
| | Developing Countries | 1 | 2017 | 236 | 0.130 |
Why?
| | Prognosis | 3 | 2021 | 3334 | 0.130 |
Why?
| | Prehypertension | 1 | 2015 | 24 | 0.130 |
Why?
| | Trans Fatty Acids | 1 | 2015 | 5 | 0.130 |
Why?
| | Risk | 1 | 2018 | 815 | 0.120 |
Why?
| | Absorptiometry, Photon | 1 | 2016 | 224 | 0.120 |
Why?
| | Aging | 2 | 2023 | 1620 | 0.120 |
Why?
| | Urban Population | 1 | 2017 | 398 | 0.120 |
Why?
| | Pregnancy Trimesters | 1 | 2014 | 13 | 0.120 |
Why?
| | Mitochondria | 1 | 2020 | 751 | 0.120 |
Why?
| | Infant, Premature | 1 | 2018 | 478 | 0.120 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2015 | 97 | 0.120 |
Why?
| | Body Weights and Measures | 1 | 2014 | 34 | 0.120 |
Why?
| | Exercise | 2 | 2023 | 1643 | 0.120 |
Why?
| | Adaptation, Physiological | 1 | 2018 | 483 | 0.110 |
Why?
| | Pediatrics | 2 | 2018 | 983 | 0.110 |
Why?
| | Los Angeles | 1 | 2013 | 56 | 0.110 |
Why?
| | New York City | 1 | 2013 | 70 | 0.110 |
Why?
| | Animals | 6 | 2021 | 31761 | 0.110 |
Why?
| | Carbonated Beverages | 1 | 2013 | 15 | 0.110 |
Why?
| | Iron Overload | 1 | 2013 | 9 | 0.110 |
Why?
| | Dietary Sucrose | 1 | 2013 | 45 | 0.110 |
Why?
| | Food, Fortified | 1 | 2013 | 36 | 0.110 |
Why?
| | Nutrition Policy | 1 | 2013 | 54 | 0.100 |
Why?
| | Vitamin A | 1 | 2012 | 52 | 0.100 |
Why?
| | Ferritins | 1 | 2012 | 52 | 0.100 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2013 | 53 | 0.100 |
Why?
| | United States | 4 | 2022 | 12175 | 0.100 |
Why?
| | Sweden | 1 | 2012 | 65 | 0.100 |
Why?
| | Maternal Age | 1 | 2012 | 117 | 0.100 |
Why?
| | Vitamin B 12 | 1 | 2012 | 115 | 0.100 |
Why?
| | Signal Transduction | 2 | 2022 | 4521 | 0.100 |
Why?
| | Folic Acid | 1 | 2012 | 161 | 0.090 |
Why?
| | Iron | 1 | 2012 | 233 | 0.090 |
Why?
| | Obesity, Morbid | 1 | 2013 | 197 | 0.090 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2013 | 216 | 0.090 |
Why?
| | Prevalence | 2 | 2013 | 2249 | 0.090 |
Why?
| | Immunization Programs | 1 | 2012 | 205 | 0.090 |
Why?
| | Zinc | 1 | 2012 | 257 | 0.080 |
Why?
| | Diet Surveys | 2 | 2021 | 78 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1134 | 0.080 |
Why?
| | Case-Control Studies | 3 | 2023 | 3004 | 0.080 |
Why?
| | Disease Progression | 1 | 2015 | 2384 | 0.080 |
Why?
| | Surveys and Questionnaires | 2 | 2018 | 4621 | 0.080 |
Why?
| | Severity of Illness Index | 2 | 2013 | 2537 | 0.080 |
Why?
| | Retrospective Studies | 2 | 2022 | 12511 | 0.080 |
Why?
| | Medicaid | 1 | 2012 | 407 | 0.080 |
Why?
| | SRS-A | 1 | 1987 | 28 | 0.070 |
Why?
| | Patient Acceptance of Health Care | 1 | 2013 | 679 | 0.070 |
Why?
| | Bronchial Provocation Tests | 1 | 1987 | 53 | 0.070 |
Why?
| | Prednisolone | 1 | 1987 | 75 | 0.070 |
Why?
| | Muscles | 2 | 2022 | 320 | 0.070 |
Why?
| | Mass Screening | 1 | 2013 | 1003 | 0.070 |
Why?
| | Reproducibility of Results | 3 | 2024 | 2762 | 0.070 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2013 | 1183 | 0.060 |
Why?
| | Academic Success | 1 | 2023 | 18 | 0.060 |
Why?
| | Child Care | 1 | 2023 | 23 | 0.050 |
Why?
| | Accelerometry | 1 | 2023 | 73 | 0.050 |
Why?
| | Parity | 1 | 2023 | 100 | 0.050 |
Why?
| | Oxylipins | 1 | 2023 | 27 | 0.050 |
Why?
| | Epigenomics | 1 | 2023 | 102 | 0.050 |
Why?
| | Sugars | 1 | 2023 | 29 | 0.050 |
Why?
| | Aged, 80 and over | 1 | 2013 | 6346 | 0.050 |
Why?
| | Adipokines | 1 | 2023 | 42 | 0.050 |
Why?
| | Life Style | 2 | 2016 | 430 | 0.050 |
Why?
| | Subcutaneous Fat, Abdominal | 1 | 2022 | 13 | 0.050 |
Why?
| | Longevity | 1 | 2023 | 137 | 0.050 |
Why?
| | Starch | 1 | 2022 | 20 | 0.050 |
Why?
| | Residence Characteristics | 1 | 2023 | 275 | 0.050 |
Why?
| | Menstrual Cycle | 1 | 2022 | 108 | 0.050 |
Why?
| | Consensus | 1 | 2023 | 535 | 0.050 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2022 | 151 | 0.050 |
Why?
| | Lipase | 1 | 2021 | 57 | 0.050 |
Why?
| | Leukocytes | 1 | 2022 | 277 | 0.050 |
Why?
| | Food | 1 | 2022 | 160 | 0.050 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2022 | 188 | 0.050 |
Why?
| | Dietary Exposure | 1 | 2020 | 7 | 0.040 |
Why?
| | Louisiana | 1 | 2020 | 24 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2022 | 331 | 0.040 |
Why?
| | Telomere | 1 | 2022 | 202 | 0.040 |
Why?
| | Alanine Transaminase | 1 | 2021 | 141 | 0.040 |
Why?
| | Genetic Markers | 1 | 2021 | 321 | 0.040 |
Why?
| | Host-Parasite Interactions | 1 | 2021 | 95 | 0.040 |
Why?
| | Energy Intake | 1 | 2023 | 427 | 0.040 |
Why?
| | Nutrition Assessment | 1 | 2020 | 75 | 0.040 |
Why?
| | Gene-Environment Interaction | 1 | 2021 | 184 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 667 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 3031 | 0.040 |
Why?
| | Eating | 1 | 2022 | 345 | 0.040 |
Why?
| | CpG Islands | 1 | 2019 | 117 | 0.040 |
Why?
| | Child Behavior | 1 | 2021 | 220 | 0.040 |
Why?
| | Public Health | 1 | 2023 | 434 | 0.040 |
Why?
| | Particulate Matter | 1 | 2020 | 185 | 0.040 |
Why?
| | Edible Grain | 1 | 2018 | 43 | 0.040 |
Why?
| | Genitalia | 1 | 2018 | 28 | 0.040 |
Why?
| | Behavior, Animal | 1 | 2021 | 460 | 0.040 |
Why?
| | Cities | 1 | 2018 | 80 | 0.040 |
Why?
| | Social Class | 1 | 2019 | 204 | 0.040 |
Why?
| | Menarche | 1 | 2018 | 49 | 0.040 |
Why?
| | Testis | 1 | 2018 | 133 | 0.040 |
Why?
| | Breast | 1 | 2018 | 141 | 0.040 |
Why?
| | Meat | 1 | 2018 | 87 | 0.040 |
Why?
| | Dietary Carbohydrates | 1 | 2018 | 139 | 0.040 |
Why?
| | Autoimmunity | 1 | 2023 | 814 | 0.040 |
Why?
| | Dietary Proteins | 1 | 2018 | 123 | 0.040 |
Why?
| | Lactation | 1 | 2018 | 151 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2018 | 348 | 0.030 |
Why?
| | Adolescent Behavior | 1 | 2021 | 489 | 0.030 |
Why?
| | Pregnancy Trimester, Second | 1 | 2016 | 66 | 0.030 |
Why?
| | Aged | 1 | 2013 | 19078 | 0.030 |
Why?
| | Weight Loss | 1 | 2020 | 642 | 0.030 |
Why?
| | Oleic Acid | 1 | 2015 | 30 | 0.030 |
Why?
| | Linoleic Acid | 1 | 2015 | 38 | 0.030 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2015 | 47 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2021 | 1022 | 0.030 |
Why?
| | Research Design | 1 | 2020 | 931 | 0.030 |
Why?
| | Vitamin D | 1 | 2018 | 341 | 0.030 |
Why?
| | Depression | 1 | 2022 | 1133 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2018 | 460 | 0.030 |
Why?
| | Notophthalmus viridescens | 1 | 1993 | 1 | 0.030 |
Why?
| | Radio | 1 | 2013 | 2 | 0.030 |
Why?
| | Salamandridae | 1 | 1993 | 26 | 0.030 |
Why?
| | Tanzania | 1 | 2013 | 44 | 0.030 |
Why?
| | Consumer Health Information | 1 | 2013 | 47 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2099 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2018 | 1214 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 1892 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1993 | 511 | 0.030 |
Why?
| | Acclimatization | 1 | 1993 | 150 | 0.030 |
Why?
| | Information Systems | 1 | 2012 | 61 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 2973 | 0.020 |
Why?
| | Models, Statistical | 1 | 2014 | 604 | 0.020 |
Why?
| | Models, Biological | 1 | 2018 | 1630 | 0.020 |
Why?
| | Reminder Systems | 1 | 2012 | 162 | 0.020 |
Why?
| | Rural Population | 1 | 2013 | 446 | 0.020 |
Why?
| | Data Collection | 1 | 2012 | 622 | 0.020 |
Why?
| | Airway Resistance | 1 | 1987 | 30 | 0.020 |
Why?
| | Vaccines | 1 | 2012 | 375 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 9089 | 0.020 |
Why?
| | Parents | 1 | 2012 | 1190 | 0.010 |
Why?
| | Quality of Life | 1 | 2013 | 2356 | 0.010 |
Why?
| | Phosphocreatine | 1 | 1993 | 36 | 0.010 |
Why?
| | Phosphates | 1 | 1993 | 158 | 0.010 |
Why?
| | Species Specificity | 1 | 1993 | 545 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1993 | 473 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1993 | 431 | 0.010 |
Why?
| | Temperature | 1 | 1993 | 575 | 0.010 |
Why?
|
|
Perng's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|